Dade Behring sets up Korean joint venture:
This article was originally published in Clinica
Dade Behring has formed a joint venture with Handok Pharmaceutical in South Korea to market and distribute lab equipment and reagents. The new company, Dade Behring Handok Diagnostics, will market Dade Behring's full line of products as well as the Eppendorf brand of precision products and will replace the company's multiple distribution channels. Dade will be the majority owner of the new company. Handok's CEO and president, Young Kim, will be executive director of the new company, while Dade's Patrick Chiu will be general manager and representative director and KiHyun Koh of Handok's diagnostics division will be representative director and will handle on-site daily operations.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.